Salem Investment Counselors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Hold |
145
| – | – | ﹤0.01% | 702 |
|
|
2025
Q1 | $21.8K | Hold |
145
| – | – | ﹤0.01% | 699 |
|
|
2024
Q4 | $26.8K | Hold |
145
| – | – | ﹤0.01% | 687 |
|
|
2024
Q3 | $28.6K | Hold |
145
| – | – | ﹤0.01% | 687 |
|
|
2024
Q2 | $30K | Hold |
145
| – | – | ﹤0.01% | 663 |
|
|
2024
Q1 | $39.3K | Hold |
145
| – | – | ﹤0.01% | 600 |
|
|
2023
Q4 | $34.3K | Hold |
145
| – | – | ﹤0.01% | 615 |
|
|
2023
Q3 | $28.4K | Hold |
145
| – | – | ﹤0.01% | 624 |
|
|
2023
Q2 | $30.5K | Hold |
145
| – | – | ﹤0.01% | 618 |
|
|
2023
Q1 | $29.3K | Hold |
145
| – | – | ﹤0.01% | 630 |
|
|
2022
Q4 | $31.6K | Hold |
145
| – | – | ﹤0.01% | 590 |
|
|
2022
Q3 | $29K | Sell |
145
-95
| -40% | -$19K | ﹤0.01% | 571 |
|
|
2022
Q2 | $51K | Buy |
240
+95
| +66% | +$20.2K | ﹤0.01% | 500 |
|
|
2022
Q1 | $41K | Hold |
145
| – | – | ﹤0.01% | 538 |
|
|
2021
Q4 | $55K | Hold |
145
| – | – | ﹤0.01% | 546 |
|
|
2021
Q3 | $60K | Hold |
145
| – | – | ﹤0.01% | 472 |
|
|
2021
Q2 | $54K | Hold |
145
| – | – | ﹤0.01% | 474 |
|
|
2021
Q1 | $42K | Buy |
145
+135
| +1,350% | +$39.1K | ﹤0.01% | 473 |
|
|
2020
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 748 |
|